Natural Experiments to Understand Plan and Provider Behavior in an Era of Accountability
了解责任时代的计划和提供者行为的自然实验
基本信息
- 批准号:10196903
- 负责人:
- 金额:$ 39.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityAcuteAffectAgeAreaCaringCoinsuranceCompetitive BiddingContractsCountyDataData SourcesDisabled PersonsElderlyEligibility DeterminationEnrollmentEvaluationEvolutionFee-for-Service PlansFoundationsGoalsHealthHealth PromotionHealth care facilityHeterogeneityHospitalsIncentivesLength of StayLinkMeasurementMeasuresMedicaidMedicareMethodologyMethodsModelingMonitorNatural experimentNatureOutcomeOutcome MeasurePatient CarePatient-Focused OutcomesPatientsPerformancePersonal SatisfactionPhysiciansPopulationPositioning AttributePrivatizationProcessProductionProspective Payment SystemProviderRandomizedResearchResidual stateResourcesRiskRisk AdjustmentServicesSkilled Nursing FacilitiesSourceSystemVariantacute careanalytical methodbasebeneficiarybundled paymentcare deliverycare outcomescostdesignexperiencefinancial incentiveflexibilitygeographic differencehealth planhigh rewardimprovedimproved outcomeinsightintrinsic motivationpatient populationpaymentphysical therapistprogramsprovider behaviorresponserisk selectionrisk sharingtoolwasting
项目摘要
ABSTRACT
Payment to providers and plans in Medicare has far-reaching implications for the health of the elderly and
disabled. The fee-for-service basis for payment has been rightly criticized for incentivizing excessive and
potentially harmful provision of care and for interfering with the production of health by linking reimbursement
to specific inputs. To establish greater flexibility and accountability, Medicare has increasingly transferred
financial risk to entities that can manage care—first to private plans in the Medicare Advantage (MA) program
and more recently to providers directly in alternative payment models (APMs) in traditional Medicare (TM). In
both models, additional payment adjustments are tied to performance on quality measures. These approaches
to integrating the financing and delivery of care create opportunities to improve patient care, but empirical
study has been challenging. Evidence on the merits of the MA program and the relative performance of MA
and APMs has been largely observational and limited in analysis of patient experiences and health outcomes.
In addition, risk contracting relies heavily on risk adjustment to profile plan or provider performance and to align
resources with the needs of patient populations, but the adequacy of risk adjustment has not been well
described. This project will make substantial contributions by leveraging natural experiments and new data to
understand plan and provider responses to payment incentives and their implications for patients and payment
system design. The project includes three aims. First, we will use natural experiments to compare performance
between MA and TM and different variants of each system. Sources of quasi-randomization to MA vs. TM will
include differences across state and county borders in MA exposure and transitions from Medicaid to dual
eligibility at age 65 in areas of high or low MA exposure. We will explore effect heterogeneity based on
geographic variation in the configuration of MA (e.g., by plan type) and TM (e.g., by APM activity). Second, we
will assess the marginal value of post-acute care in skilled nursing facilities (SNFs) and effects of incentives to
alter post-acute length of stay on patient outcomes in different payment models, including TM, MA, and APMs.
Post-acute care is an area of intense activity in MA and APMs that offers insights into provider agency.
Approaches will make use of discontinuities in SNF reimbursement and coinsurance related to length of stay
and natural randomization of patients to physical therapists in hospitals. Third, we will determine the extent to
which risk-adjusted MA-TM differences in outcomes reflect performance differences vs. residual risk selection
and assess the adequacy of risk-adjustment methods. We will use strategies from our first aim to compare MA-
TM performance differences in self-sorted vs. quasi-randomized populations. Findings will characterize the
prospects for value-enhancing competition or unintended consequences from prospective payment systems
and will have important implications for the validity of quality scores. Thus, the project will provide foundational
evidence and insights for improving health through payment systems and performance monitoring.
抽象的
向提供者付款和Medicare计划对老年人的健康和
禁用。付款费用的支付基础已被正确化,以激励过量和
潜在的有害提供护理和通过连接报销来干扰健康的生产
到特定的输入。为了建立更大的灵活性和问责制,医疗保险已经增加了
对可以管理护理的实体的财务风险 - 首先是Medicare Advantage(MA)计划的私人计划
最近,直接在传统医疗保险(TM)中直接使用替代支付模型(APMS)的提供商。
两种模型,额外的付款调整都与质量措施的绩效相关。这些方法
整合融资和提供护理的融资创造了改善患者护理的机会,但经验
研究受到挑战。关于MA计划的优点和MA的相对表现的证据
APM在很大程度上是观察性的,并且在分析患者经验和健康结果方面有限。
此外,风险收缩在很大程度上依赖于对个人资料计划或提供商绩效的风险调整,并保持一致
有患者人群需求的资源,但风险调整的充分性还不错
描述。该项目将通过利用自然实验和新数据来为
了解计划和提供者对付款激励措施的回应及其对患者的影响和付款
系统设计。该项目包括三个目标。首先,我们将使用自然实验比较性能
在MA和TM之间以及每个系统的不同变体之间。准随机化的来源
在MA暴露和从医疗补助到双重的过渡中包括各州和县边界的差异
在高或低MA暴露区域的65岁时资格。我们将基于
MA配置的地理变化(例如,按计划类型)和TM(例如,通过APM活动)。第二,我们
将评估熟练护士设施(SNF)急性后护理的边际价值,并激励措施对
在包括TM,MA和APM在内的不同付款模型中的患者结局上更改急性后住院时间。
急性后护理是MA和APM中激烈活动的领域,可提供对提供商代理的见解。
方法将利用与住宿时间有关的SNF报销和共同保险中的不连续性
和医院中物理治疗师的自然随机化。第三,我们将确定
哪些风险调整后的MA-TM差异反映了绩效差异与剩余风险选择
并评估风险调整方法的充分性。我们将使用第一个目标中的策略来比较MA-
自我分级与准随机群体的TM性能差异。调查结果将表征
潜在的竞争前景或预期支付系统的意外后果
并将对质量分数的有效性具有重要意义。那将提供基础
通过支付系统和绩效监控来改善健康的证据和见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Michael McWilliams其他文献
John Michael McWilliams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Michael McWilliams', 18)}}的其他基金
Reforming Medicare: Beneficiary Choice, Plan Payment, and Accountable Care
改革医疗保险:受益人选择、计划付款和责任医疗
- 批准号:
8314022 - 财政年份:2010
- 资助金额:
$ 39.28万 - 项目类别:
Reforming Medicare: Beneficiary Choice, Plan Payment, and Accountable Care
改革医疗保险:受益人选择、计划付款和责任医疗
- 批准号:
8143466 - 财政年份:2010
- 资助金额:
$ 39.28万 - 项目类别:
Reforming Medicare: Beneficiary Choice, Plan Payment, and Accountable Care
改革医疗保险:受益人选择、计划付款和责任医疗
- 批准号:
8014617 - 财政年份:2010
- 资助金额:
$ 39.28万 - 项目类别:
Improving Medicare in an Era of Change: Natural experiments to understand protective effects of Medicaid and Medicare policy during the COVID-19 pandemic for populations with a high rates of dementia
在变革时代改善医疗保险:通过自然实验了解 COVID-19 大流行期间医疗补助和医疗保险政策对痴呆症高发人群的保护作用
- 批准号:
10287696 - 财政年份:2009
- 资助金额:
$ 39.28万 - 项目类别:
Natural Experiments to Understand Plan and Provider Behavior in an Era of Accountability
了解责任时代的计划和提供者行为的自然实验
- 批准号:
10379882 - 财政年份:2009
- 资助金额:
$ 39.28万 - 项目类别:
Natural Experiments to Understand Plan and Provider Behavior in an Era of Accountability
了解责任时代的计划和提供者行为的自然实验
- 批准号:
10616700 - 财政年份:2009
- 资助金额:
$ 39.28万 - 项目类别:
Project 3: Effects of ACOs in Medicare on Utilization and Quality: Heterogeneity
项目 3:医疗保险中 ACO 对利用和质量的影响:异质性
- 批准号:
9110084 - 财政年份:
- 资助金额:
$ 39.28万 - 项目类别:
Project 3: Effects of ACOs in Medicare on Utilization and Quality: Heterogeneity
项目 3:医疗保险中 ACO 对利用和质量的影响:异质性
- 批准号:
8793357 - 财政年份:
- 资助金额:
$ 39.28万 - 项目类别:
Project 3: Effects of ACOs in Medicare on Utilization and Quality: Heterogeneity
项目 3:医疗保险中 ACO 对利用和质量的影响:异质性
- 批准号:
9756140 - 财政年份:
- 资助金额:
$ 39.28万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SSRP1/Sp-1转录调控的MFGE8通过SIRT6影响铁死亡在脓毒症急性肾损伤中的机制研究
- 批准号:82302418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人群mtDNA空间异质性对急性高原反应发病的影响机制研究
- 批准号:42377466
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
高甘油三酯通过TLR4/caspase-8影响急性胰腺炎CD4+T细胞程序性死亡的机制研究
- 批准号:82360135
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
I-TRANSFER-HF: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe: A Type 1 Hybrid Effectiveness Implementation Trial
I-TRANSFER-HF:改善家庭医疗保健中心力衰竭患者的过渡和结果:1 型混合有效性实施试验
- 批准号:
10714524 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Extraction of Vital Signs using a Telehealth Application for Asthma - EViTA-AThe purpose of this grant is to evaluate mobile devices to extract vitals signs to monitor patients with Asthma
使用哮喘远程医疗应用程序提取生命体征 - EViTA-A 这项拨款的目的是评估移动设备提取生命体征以监测哮喘患者
- 批准号:
10699530 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Effect of Medicaid Accountable Care Organizations on Behavioral Health Care Quality and Outcomes for Children
医疗补助责任护理组织对儿童行为保健质量和结果的影响
- 批准号:
10729117 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Achieving Maternal Equity and Transforming Health through Implementation Science and Training (AMETHIST@Penn)
通过实施科学和培训实现孕产妇公平并改变健康状况 (AMETHIST@Penn)
- 批准号:
10748593 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别: